logologo
QuantliQuantli

Compass Therapeutics Inc.

CMPX

NASDAQ

Biotechnology

$2.25

USD

-0.01 (-0.44%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $407.00M

Volume 1.4M

Price (USD)
Price (USD)

About Compass Therapeutics Inc.

The company is headquartered in Boston, Massachusetts and currently employs 39 full-time employees. The company went IPO on 2020-11-13.

CEO

Dr. Thomas Schuetz

HQ

Boston, MASSACHUSETTS, US

Founded

2020

Employees

39

Key Metrics

2 metrics our research team weighs before forming a view on CMPX.

Based on Quantli research · SEC filings · as of Q2 2026

METRIC

VALUE

CHANGE

TREND (3Y)

ROE (TTM)

-44.2%

+22.3 pp

Free Cash Flow (TTM)

$-56.38M

Financial Snapshot

Full Financials

Revenue

$0

YoY

Gross Margin

YoY

Net Income

$-73.45M

-18.4%

YoY

Operating Cash Flow

$-56.11M

-24.0%

YoY

Key Statistics

Open

$2.30

Previous Close

$2.26

Day Range

$2.23 - $2.30

52 Week Range

$1.61 - $6.88

Volume

1.4M

Average Volume (10 Days)

4.2M

Dividend Yield

Valuation Measurement

Market Cap

$407.00M

P/E Ratio (TTM)

Price / Book

2.45

Financial Highlights

Return on Assets

-38.6%

Return on Equity

-44.2%

Revenue (TTM)

$0

Net Income (TTM)

$-73.45M

Diluted EPS (TTM)

-$0.39

Total Cash (MRQ)

$35.45M

Levered FCF (TTM)

$-56.38M

Turn research into action

Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.

Swing Strategy

Buy support, sell on recovery.

Best for:

Risk-tolerant

Trend Following

Enter on trend. Cut losses fast.

Best for:

Active traders

Position Strategy

Ride market cycles. Patient hold.

Best for:

Patient investors

Go deeper on CMPX

Similar Stocks

CAPR

Capricor Therapeutics Inc

$6.65

+58.0%

RZLT

Rezolute Inc

$4.60

0.0%

FENC

Fennec Pharmaceuticals Inc

$11.72

-2.8%

PRLD

Prelude Therapeutics Inc

$5.55

+3.5%

EDIT

Editas Medicine Inc

$2.82

+0.4%

ENTA

Enanta Pharmaceuticals Inc

$13.16

-2.1%

PROK

Prokidney Corp

$1.33

-5.3%

LXEO

Lexeo Therapeutics Inc

$4.84

-2.4%

BNTC

Benitec Biopharma Inc

$12.56

0.0%

Earnings Calendar

Next Earnings

Estimated Q3 Release

Nov 03

Est. EPS

Adjusted consensus estimate

-$0.12